1. Home
  2. COHN vs DRIO Comparison

COHN vs DRIO Comparison

Compare COHN & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

HOLD

Current Price

$11.08

Market Cap

54.3M

Sector

Finance

ML Signal

HOLD

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$8.11

Market Cap

60.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHN
DRIO
Founded
1999
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.3M
60.6M
IPO Year
2003
2013

Fundamental Metrics

Financial Performance
Metric
COHN
DRIO
Price
$11.08
$8.11
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
39.9K
6.0K
Earning Date
05-01-2026
05-14-2026
Dividend Yield
4.35%
N/A
EPS Growth
5537.50
1559.02
EPS
0.42
1.25
Revenue
$275,564,000.00
$7,394,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
N/A
$47.58
P/E Ratio
$25.95
$6.04
Revenue Growth
246.19
43.02
52 Week Low
$7.78
$0.38
52 Week High
$32.60
$17.74

Technical Indicators

Market Signals
Indicator
COHN
DRIO
Relative Strength Index (RSI) 34.38 48.37
Support Level $10.89 $7.29
Resistance Level $12.79 $9.46
Average True Range (ATR) 1.12 0.46
MACD -0.38 -0.01
Stochastic Oscillator 19.13 37.89

Price Performance

Historical Comparison
COHN
DRIO

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: